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Orofacial clefts (OFC) are complex genetic traits that are often classified as syn-
dromic or nonsyndromic clefts. Currently, there are over 500 types of syndro-
mic clefts in the Online Mendelian Inheritance in Man (OMIM) database, of
which Van der Woude syndrome (VWS) is one of the most common (account-
ing for 2% of all OFC). Popliteal pterygium syndrome (PPS) is considered to
be a more severe form of VWS. Mutations in the IRF6 gene have been reported
worldwide to cause VWS and PPS. Here, we report studies of families with
VWS and PPS in sub-Saharan Africa. We screened the DNA of eight families
with VWS and one family with PPS from Nigeria and Ethiopia by Sanger
sequencing of the most commonly affected exons in IRF6 (exons 3, 4, 7, and
9). For the VWS families, we found a novel nonsense variant in exon 4
(p.Lys66X), a novel splice-site variant in exon 4 (p.Pro126Pro), a novel mis-
sense variant in exon 4 (p.Phe230Leu), a previously reported splice-site variant
in exon 7 that changes the acceptor splice site, and a known missense variant
in exon 7 (p.Leu251Pro). A previously known missense variant was found in
exon 4 (p.Arg84His) in the PPS family. All the mutations segregate in the fami-
lies. Our data confirm the presence of IRF6-related VWS and PPS in sub-Saha-
ran Africa and highlights the importance of screening for novel mutations in
known genes when studying diverse global populations. This is important for
counseling and prenatal diagnosis for high-risk families.
Introduction
Orofacial clefts (OFC) are complex genetic traits that are
often classified as syndromic or nonsyndromic clefts. To
date, over 500 syndromic clefts have been identified and
included in the Online Mendelian Inheritance in Man
(OMIM) database (www.omim.org), and for many of
these the underlying genetic factors have been identified.
Van der Woude syndrome (VWS) (OMIM:119300) is an
autosomal dominant disorder affecting 1/40,000 people
worldwide (Lam et al. 2010) and also one of the most
common syndromic cleft, accounting for 2% of all OFC
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(Rizos and Spyropoulos 2004). Popliteal pterygium syn-
drome (PPS) (OMIM:119500) is a rare autosomal domi-
nant disorder affecting 1/300,000 people worldwide
(Froster-Iskenius 1990) and in most cases is allelic, but
more severe form of VWS. VWS/PPS are unique amongst
syndromic OFC; in which cleft can either be of the lip or
of the palate in the same pedigree.
Mutations in the IRF6 gene (OMIM:607199) have been
reported worldwide to cause VWS and PPS (Kondo et al.
2002; De Lima et al. 2009; Birkeland et al. 2011; Mi~nones-
Suarez et al. 2012; Salahshourifar et al. 2012; Leslie et al.
2013; Malik et al. 2013; Tan et al. 2013).To date, about 300
mutations causing VWS and PPS have been reported in
different populations across the world (Leslie et al. 2013)
and these include missense, nonsense, and frameshift, mic-
rodeletions and splice-site mutations. These mutations are
nonrandomly distributed and observed to be enriched in
exon 4, which is in the highly conserved DNA-binding
domain and in exon 7 and 9, which are in the less-con-
served protein-binding domain (De Lima et al. 2009; Leslie
et al. 2013). None of the 300 mutations previously reported
included cases from sub-Saharan Africa and there is no
information on the genetic causes of VWS in this popula-
tion. In order to investigate the genetic causes of VWS in
sub-Saharan African population, we obtained saliva samples
from eight families with VWS and one PPS from Nigeria
and Ethiopia for Sanger sequencing of the most commonly
affected exons in IRF6 (3, 4, 7, and 9).
Methods
Samples
The samples used for this genetic study were obtained
as part of a larger study on genetics of orofacial clefts
(Nigerian Craniofacial Anomalies Research Network
[NigeriaCRAN] and Ethiopia Craniofacial Anomalies
Research Network [EthiopiaCRAN]). Ethical approval was
obtained from the Institutional Review Boards at the
Lagos University Teaching Hospital, Lagos (IRB approval
number: ADM/DCST/HREC/VOL.XV/321), Obafemi
Awolowo University Teaching Hospital Ile-Ife (IRB
approval number: ERC/2011/12/01), and the Addis Ababa
University (IRB approval number: 003/10/surg). Written
informed consent was obtained from every family
recruited. We collected samples from affected proband,
both parents, and from available affected and unaffected
relatives. The Oragene collection kit (www.dnagenotek.
com) was used to collect saliva samples from adults and
children. For the newborn and children who were unable
to spit, we used saliva sponges to soak saliva sublingually
or in the buccal sulcus and these sponges were then
placed into the Oragene collection kits.
The samples were then shipped to the Murray Labora-
tory in Iowa, for DNA processing and sequencing. The
protocol for DNA processing is available on the Murray
Lab website (http://genetics.uiowa.edu/protocols.php).
The DNA samples concentration was measured using a
Qubit 2.0 Fluorometer (http://www.invitrogen.com/site/us/
en/home/brands/Product-Brand/Qubit.html) and a 4 ng/
lL was used for Sanger sequencing.
Clinical information
For a diagnosis of VWS to be made, lower lip pits must
be present in one or several members of a family in addi-
tion to cleft of the lip and/or palate. The diagnosis of PPS
is made when features of VWS are present in a family in
addition to a popliteal web in the popliteal fossa.
The nine families studied were as follows (Fig. 1):
Family 1: Patient 1 had complete bilateral cleft of the
lip and palate (BCLP) and bilateral lower lip pits that has
been repaired. Patient 2 had complete BCLP and unre-
paired bilateral lower lip pits which appear as two distinct
bulges. Patient 3 (mother) has unrepaired bilateral lower
lip pits which are shallow and phenotypically different
from the lip pits in patient two. Patient 4 (deceased
maternal granddad) had a cleft lip (CL).
Family 2: Patient 1 had BCLP and Patient 2 (mother)
has bilateral lower lip pits which are shallow and without
a sinus.
Family 3: Patient 1 had cleft of the hard palate only
(CPO) and bilateral lower lip pits which are shallow and
without a sinus. Both parents appear clinically normal.
Family 4: Patient 1 had right incomplete cleft of the
lip. Both parents appear clinically normal.
Family 5: Patient 1 had left incomplete cleft of the lip
and bilateral lower lip pits. The elder sister was reported
to have cleft with no specific details on the type. The
father appears clinically normal.
Family 6: Patient 1 had complete left unilateral CLP and
popliteal web on the right leg. Patient 2 (mother) had right
unilateral cleft of the primary palate and popliteal web on
the right leg. Patient 3 (maternal grandmother) was
reported to have cleft with no specific details on the type.
Sequencing
The method used for sequencing has been previously
reported (Butali et al. 2013). In summary, we used the
primer sets that were designed by De Lima et al. (2009)
to sequence all the exons in the IRF6 gene
(NM_006147.2). A master mix containing 10 9 NH4
buffer, 5% dimethyl sulphide (DMSO), 200 lmol/L deoxy-
ribonucleotide triphosphates (DNTPs), 50 lmol/L MgCl,
water, 20 lmol/L of forward and reverse primers, and the
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5 U/lL Taq polymerase enzyme was prepared. We added
9 lL of the master mix to 1 lL of DNA in a 96-well
plate. Two Centre d’Etude du Polymorphisme Humain
(CEPH) samples and two water samples were added as
controls. The list of primers and annealing temperatures
are available at the Murray laboratory (http://genetics.ui-
owa.edu/protocols.php). Amplified DNA products were
sent to Functional Biosciences in Madison, Wisconsin
(http://order.functionalbio.com/seq/index) for sequencing
using an ABI 3730XL (http://www.appliedbiosystems.com/
absite/us/en/home.html). Chromatograms were transferred
to a Unix workstation, base-called with PHRED (http://
www.phrap.org/phredphrapconsed.html) (v.0.961028), as-
sembled with PHRAP (http://www.phrap.org/) (v.
0.960731), scanned by POLYPHRED (http://droog.gs.
washington.edu/polyphred/) (v. 0.970312), and viewed
with the CONSED program (http://www.phrap.org/
consed/consed.html) (v. 4.0). In probands with rare func-
tional variants, we sequenced samples from their parents
and relatives to confirm mutations that are de novo or
segregating in the family. We then compared the muta-
tions found in this study to mutations that are present in
the African population and other populations in the 1000
genome (1KG) database (http://www.1000genomes.org/)
and the two populations in the exome variant sequence
(EVS) database (http://snp.gs.washington.edu/EVS/). All
coding mutations were submitted into the locus-specific
database (http://www.centralmutations.org/LsdbAdd.php).
We predicted the functional effects of these variants on
the protein by using bioinformatics tools such as poly-
phen (http://genetics.bwh.harvard.edu/pph2/) (Adzhubei







Figure 1. Pedigrees of the three VWS and PPS families. The black arrows point to the bilateral lower lip pits in the VWS families and popliteal
web in the right popliteal fossa in the PPS family.
Figure 2. Schematic structures of the original leucine and the mutant
(proline) at amino acid position 251. The backbone, which is the
same for each amino acid, is colored red. The side chain, unique for
each amino acid, is colored black.
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2009) and HOPE (http://www.cmbi.ru.nl/hope) (Vens-
elaar et al. 2010).
Results
We found six different heterozygous mutations (Figs.
S1–S5) in the families investigated (Table 1). In family 1,
we found a novel nonsense variant in exon 4 (p.Lys66X).
We found a novel splice-site variant in exon 4 (p.Pro126-
Pro) in family 2. In family 3, we found a previously
reported splice-site variant in exon 7 that changes the
acceptor splice site. We found two variants in exon 7; a
previously reported variant (p.Leu251Pro) (Figure 2) in
family 4 and a novel variant (p.Phe230Leu) (Figure 3) in
family 5. A previously known missense variant was found
in exon 4 (p.Arg84His) (Figure 4) in family 6. All the
mutations segregate in the families. Analyses using HOPE
suggest that the proline introduced by the variant is a
very rigid residue and this might abolish the required
flexibility of the protein at this position. The residue is
buried in the core of a domain and the differences
between the wild-type and mutant residue might disturb
the core structure of this domain. The mutant residue is
smaller than the wild-type residue and the mutation will
cause an empty space in the core of the protein.
HOPE reveals that in the 3D structure, the wild-type
residue is located in its preferred secondary structure, a
b-strand and the mutant residue prefers to be in another
secondary structure. Therefore, the local conformation
Figure 3. Schematic structures of phenylalanine into a leucine at position 230. The backbone, which is the same for each amino acid, is colored
red and the side chain which is unique for each amino acid is colored black.
Figure 4. Schematic structures of an arginine into a histidine at
position 84. The backbone, which is the same for each amino acid, is
colored red and the side chain, unique for each amino acid, is colored
in black.
Table 1. Showing families with VWS and PPS syndromes from Nigeria and Ethiopia, variants found and predicted functional effects on the
protein.
Families Country Diagnosis DNA mutation1
Protein
mutation2 Polyphen/SIFT predictions 1KG/EVS
1 Ethiopia VWS c.196A>T p.Lys66X Premature stop 0
2 Nigeria VWS c.551 T>A Splice site 0
3 Nigeria VWS c.1061-2A>G Splice site Changes acceptor site 0
4 Nigeria VWS c.752T>C p.Leu251Pro Probably damaging/deleterious 0
5 Ethiopia VWS c.690T>G p.Phe230Leu Probably damaging/tolerated 0
6 Nigeria PPS rs121434227G>A p.Arg84His Probably damaging 0
1KG, 1000 genomes; EVS, exome variant server.
1NM_006147.2
2NP_006138
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will be slightly destabilized. The residue is buried in the
core of a domain and the differences between the wild-
type and mutant residue might disturb the core structure
of this domain. The mutant residue is smaller than the
wild-type residue and this will cause an empty space in
the core of the protein.
HOPE suggests that the wild-type residue is bigger and
was positively charged and the mutant residue is neutral
and smaller. This means that the charge of the buried
wild-type residue is lost by this mutation. The residue has
DNA interactions or is located in a DNA-binding region
and the differences in the properties between wild-type
and mutant residue can easily cause loss of these interac-
tions or disturb the domain that will affect the function
of the protein. In addition, the mutant residue is located
near a highly conserved position. Furthermore, the differ-
ences between the wild-type and mutant residue might
disturb the core structure of this domain as the residue is
buried in the core domain that will cause an empty space
in the core of the protein. Therefore, this mutation is
possibly damaging.
Discussion
We found six different mutations in VWS and PPS fami-
lies from two populations in sub-Sahara. The nonsense
variant (p.Lys66X) is novel and never been previously
reported, thus suggesting that it is specific to this popula-
tion. This variant was found in exon 4 leading to the for-
mation of a premature stop codon and truncation of the
protein. This leads to haploinsufficiency of the IRF6 gene;
a previously described mechanism for VWS (Kondo et al.
2002). We also found a novel synonymous variant in
exon 4 that is 1 bp from the canonical donor splice site
in intron 5. Scioletti et al. (2010) previously reported a
splice-site variant in intron 4 that affects the acceptor site
using the Human Splicing Finder (HSF v.2.4, http://www.
umd.be/HSF/). The novel splice-site variant in this study
is not predicted to have any effect on splicing when we
conducted bioinformatic analysis using the HSF. The
splice-site variant in intron 7 was previously reported in a
Brazilian Family (De Lima et al. 2009).
The missense mutation (p. Leu251Pro) was previously
reported in a Belgian family (Ghassibe et al., 2004).
HOPE analyses of the missense variant suggest that
Proline; a rigid residue abolishes the flexibility of IRF6
protein at this position leading to an altered IRF6 gene
product. Therefore, p.Leu251Pro is a dominant negative
mutation and will affect the molecular function of the
gene. The dominant negative mechanism has been previ-
ously described for VWS and PPS syndromes (Kondo
et al. 2002; Item et al. 2005). The novel missense variant
(p.Phe230Lue) is a dominant negative mutation that acts
antagonistically to the wild type leading to disturbances
in the conformity of the protein. The missense variant
found in the PPS family (p. Arg84His) is also a domi-
nant negative mutation and one of the two major muta-
tions that are frequently reported for PPS (De Lima
et al. 2009; Leslie et al. 2013). This study provides data
on the geographical spread of the variant and role in
PPS etiology.
In three of the families with VWS, we did not find any
mutation in the IRF6 gene. This is not surprising as 25%
of families with VWS do not have a mutation in the IRF6
gene (De Lima et al. 2009). It is possible that mutations
at a different locus or loci account for the etiology of
VWS in these families. A recent study identified a second
locus in chromosome 1 through linkage and exome
sequencing studies (Peyrard et al. 2013). Fine mapping of
this region using Sanger sequencing suggests that muta-
tions in the grainy-head like three (GRHL3) gene contrib-
utes to 3–5% of cases with VWS. In the remaining 20%
of cases, it is possible that there may be large deletions
that take out the IRF6 gene or other regions in the gen-
ome. Exome sequencing of these samples is planned and
this will unravel additional etiological locus or loci
involved.
The different lip phenotypes observed in this study
(e.g., lip pits and lip bulbs) suggest that there are major
and minor lip phenotypes in VWS. This observation is
consistent with the lip phenotypes described in previous
studies (Desmyter et al. 2010; Salahshourifar et al. 2012).
Furthermore, three of the individuals with VWS and the
individual with PPS were initially diagnosed as nonsyn-
dromic following clinical examination. However, muta-
tion screen in the IRF6 gene confirmed these individuals
to be VWS and PPS, respectively. Therefore, it is essential
for all previously described cases of nonsyndromic clefts
to be examined for these minor VWS phenotypes and
mutations in the IRF6 gene.
Our data confirm the presence of IRF6-related VWS
and PPS in sub-Saharan Africa and highlight the impor-
tance of screening for novel mutations in known genes
when studying diverse global populations. Screening other
exons of the gene may be useful, especially if the most
commonly affected exons show no mutation. This is
important for counseling and prenatal diagnosis for high-
risk families, especially in Africa where there are limited
genetic counselors.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Chromatogram showing a single-nucleotide
change from A to C at position 498 in exon 7. This
nucleotide change led to a missense mutation (p.Phe230-
Leu).
Figure S2. Chromatogram showing a single-nucleotide
change from T to A at position 290 in exon 4. This
nucleotide change led to a nonsense mutation (p.Lys66X).
Figure S3. Chromatogram showing a single-nucleotide
change from T to C at position 348 2 base pairs from
exon 8. This nucleotide change led to the creation of a
potential new acceptor splice site in exon 8.
Figure S4. Chromatogram showing a single-nucleotide
change from A to G at position 424 in exon 7. This
nucleotide change led to a missense mutation (p. Leu251-
Pro).
Figure S5. Chromatogram showing a single-nucleotide
change from A to G at position 247 in exon 4. This
nucleotide change led to a missense mutation
(p. Arg84His).
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